Agents and Actions

, Volume 22, Issue 3–4, pp 295–301 | Cite as

Mode of activation of the metabolic burst in polymorphonuclear leukocytes by calcium oxalate crystals

  • J. G. R. Elferink
Immunosuppression and Inflammation

Abstract

Microcrystals of calcium oxalate cause an activation of the metabolic burst in polymorphonuclear leukocytes, measured as NBT reduction. Crystal-induced NBT reduction, which was mainly due to superoxide release, was accompanied by enzyme release. Modulation of calcium oxalate-induced activation by several agents resembles the effect of these agents on activation by opsonized zymosan and by phorbol myristate acetate. Both the activation of the metabolic burst and concomitant enzyme release could be counteracted by certain anions, such as oxalate, pyruvate and citrate, indicating that positive charges on the crystals play an important role in crystal-cell interaction. Removal of the negatively charged sialic acid from the cell surface by neuraminidase did not affect the action of the crystals. The mechanism, by which calcium oxalate activates polymorphonuclear leukocytes, is discussed.

Keywords

Calcium Citrate Superoxide Pyruvate Oxalate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    G. Weissmann, R. B. Zurier, P. J. Spieler and J. H. Goldstein,Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles, J. Exp. Med.134, 1493–1655 (1971).Google Scholar
  2. [2]
    A. C. Allison, J. S. Harrington and M. Birbeck,An examination of the cytotoxic effects of silica on macrophages, J. Exp. Med.124, 141–154 (1966).CrossRefPubMedGoogle Scholar
  3. [3]
    H. R. schumacher, P. Fischbein, P. Philps, R. Tse and R. Krauser,Comparison of sodium urate and calcium pyrophosphate crystal phagocytosis by polymophonuclear leukocytes, Arthritis Rheum.18, 783–792 (1975).PubMedGoogle Scholar
  4. [4]
    C. W. Denko and M. W. Whitehouse,Experimental inflammation induced by naturally occurring microcrystalline calcium salts, J. Rheumatol.3, 54–62 (1976).PubMedGoogle Scholar
  5. [5]
    P. A. Dieppe,Crystal deposition and inflammation, Quart. J. Med.53, 309–316 (1984).PubMedGoogle Scholar
  6. [6]
    C. W. Denko and M. Petricevic,Sympathetic or reflex footpad swelling due to crystal-induced inflammation in the opposite foot, Inflammation3, 81–86 (1978).CrossRefPubMedGoogle Scholar
  7. [7]
    G. S. Hoffman, H. R. Schumacher, H. Paul, V. Cherian, R. Reed, A. G. Ramsay and W. A. Franck,Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann. Intern. Med.97, 36–42 (1982).PubMedGoogle Scholar
  8. [8]
    M. A. Boogaerts, D. E. Hammerschmidt, C. Roelant, R. L. Verwilghen and H. S. Jacob,Mechanisms of vascular damage in gout an oxalosis: crystal-induced, granulocyte-mediated endothelial injury, Thromb. Haemostas.50, 576–580 (1983).Google Scholar
  9. [9]
    G. Gherardi, A. Poggi, S. Sisca, V. Calderaro and E. Bonucci,Bone oxalosis and renal osteodystrophy, Arch. Pathol. Lab. Med.104, 105–111 (1980).PubMedGoogle Scholar
  10. [10]
    N. D. Adams, G. F. Carrera, R. P. Johnson, R. Latorraea and J. Lemann,Calcium oxalate crystal-induced bone disease, Amer. J. Kidney Dis.1, 294–299 (1982).Google Scholar
  11. [11]
    J. G. R. Elferink and J. C. Riemersma,Calcium oxalate crystal-induced cytolysis in polymorphonuclear leukocytes and erythrocytes, Agents Actions10, 439–444 (1980).CrossRefPubMedGoogle Scholar
  12. [12]
    J. G. R. Elferink and M. Deierkauf,Enzyme release from polymorphonuclear leukocytes during the interaction with calcium oxalate microcrystals, J. Urol. (1987) in press.Google Scholar
  13. [13]
    J. C. Fantone and P. A. Ward,Role of oxygen-derived free radicals and metabolites in leukocytes-dependent inflammatory reaction, Amer. J. Pathol.107, 397–418 (1982).Google Scholar
  14. [14]
    J. G. R. Elferink,Measurement of the metabolic burst in human neutrophils: a comparison between cytochrom c and NBT reduction, Res. Commun. Chem. Pathol. Pharmacol.43, 339–342 (1984).PubMedGoogle Scholar
  15. [15]
    J. G. R. Elferink and M. Deierkauf,Inhibition of polymorphonuclear leukocyte functions by chloretracycline, Biochem. Pharmacol.33, 3667–3673.Google Scholar
  16. [16]
    Gmelin's Handbuch der Anorganischen Chemie, Nr. 28.Calcium Teil B, Lieferung 3. Verlag Chemie, Weinheim, 1961, p. 998.Google Scholar
  17. [17]
    L. Warren,The thiobarbituric assay of sialic acids, J. Biol. Chem.234, 1971–1975 (1959).PubMedGoogle Scholar
  18. [18]
    P. Hasselbacher,Stimulation of synovial fibroblasts by calcium oxalate and monosodium urate monohydrate, J. Lab. Clin. Med.100, 977–985 (1982).PubMedGoogle Scholar
  19. [19]
    J. G. R. Elferink and J. C. Riemersma,Hydroxyapatite crystal-induced membrane damage in granulocytes and erythrocytes, Agents Actions13, 515–516 (1983).Google Scholar
  20. [20]
    J. G. R. Elferink,Crystal-induced membrane damage: hydroxyapatite crystal-induced hemolysis of erythrocytes, Biochem. Med. Metabol. Biol.36, 25–35 (1986).CrossRefGoogle Scholar
  21. [21]
    W. W. Nauseef, J. A. Metcalf and R. K. Root,Role of myeloperoxidase in the respiratory burst of human neutrophils, Blood61, 483–492 (1983).PubMedGoogle Scholar
  22. [22]
    A. Deisseroth and A. L. Dounce,Catalase: physical and chemical properties: mechanism of catalysis, and physiological role, Physiol. Revs.50, 319–375 (1970).Google Scholar

Copyright information

© Birkhäuser Verlag 1987

Authors and Affiliations

  • J. G. R. Elferink
    • 1
  1. 1.Department of Medical Biochemistry, Sylvius LaboratoriesUniversity of LeidenLeidenThe Netherlands

Personalised recommendations